abs10.txt	objective		to	examine	intravesical	chemotherapy	(ivc)	use	according	non-muscleinvasive	bladder	cancer	(nmibc)	patient	disease	risk	and	the	contributions	ofmulti-level	factors	variation	in	proficient	among	patients	withlow-intermediate	methods	this	study	included	988	diagnosed	with	nmibc	an	integratedhealth	system	northern	california	from	2015-2017	we	calculated	ivc	receipt	bydisease	low-intermediate	assessed	therelationship	between	multi-level	using	a	logisticregression	model	random	intercepts	for	provider	service	area	andpatient-	provider-	area-level	fixed	effects	further	assessedthe	association	of	byexamining	intra-class	correlation	coefficients	(iccs)	results	similar	proportions	(36%)	high-risk	(34%)patients	received	multivariate	analysis	including	low-intermediaterisk	volume	was	strongly	statistically	significantlyassociated	(aor	high-	v	low-volume	0	08	95%	ci	01-0	58)	iccs	were	large	(38%	p=0	0009	39%	03	respectively)	indicating	that	much	variance	explained	byfactors	at	these	levels	conclusion	our	findings	highlight	opportunities	improve	ofivc	future	research	should	assess	practice-level	barriers	ivcuse
